COMMUNIQUÉS West-GlobeNewswire

Tizona Therapeutics Presents Phase 1b TTX-080 Clinical Data in Advanced Colorectal Cancer and Head and Neck Squamous Cell Carcinoma at ASCO 2024
23/05/2024
TTX-080 plus EGFR Inhibitor Cetuximab Demonstrated Promising Evidence of Clinical Activity in Patients with Biomarker-Defined Metastatic Colorectal Cancer and Locally Advanced/Metastatic Head and Neck Squamous Cell [...]
Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting
23/05/2024
ARTISTRY-3 trial is being conducted to evaluate less frequent dosing of nemvaleukin alfa, Mural’s late-stage lead candidate Nemvaleukin demonstrated pharmacodynamic proof of mechanism in ARTISTRY-3 and was generally [...]
Philips successfully prices offering of Notes for EUR 700 million to be used for repayment of existing debt
23/05/2024
May 23, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the successful pricing of its offering of EUR 700 million fixed rate notes due 2032 ( [...]
Inotiv, Inc. to Participate in Upcoming Craig Hallum and Jefferies Investor Conferences
23/05/2024
WEST LAFAYETTE, Ind., May 23, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development [...]
NANOBIOTIX to Present at the Jefferies Global Healthcare Conference
23/05/2024
PARIS and CAMBRIDGE, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘ Company ’’), a late-clinical stage biotechnology company pioneering physics-based approaches to expand [...]
NANOBIOTIX participera à la conférence Jefferies Global Healthcare
23/05/2024
PARIS et CAMBRIDGE, Mass., 23 mai 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –– NASDAQ : NBTX – la « Société » ), société française de biotechnologie en phase de développement clinique avancé, pionnière des [...]
CooperCompanies’ 2023 Environmental, Social, and Governance Report Highlights Efforts that Benefit People and the Planet
23/05/2024
SAN RAMON, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) today released its 2023 Environmental, Social, and Governance (ESG) Report . The report showcases the company’s progress on enhancing the [...]
Kane Biotech Announces First Quarter 2024 Financial Results
23/05/2024
WINNIPEG, Manitoba, May 23, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces its first quarter 2024 financial results. The Company previously [...]
LifeStance to Participate in Upcoming Investor Conferences
23/05/2024
SCOTTSDALE, Ariz., May 23, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, today announced that management will participate [...]
Hornet Therapeutics emerges from stealth with data published in Science demonstrating the first potential drug intervention for Epstein-Barr Virus (EBV) driven disease
23/05/2024
Press Release Hornet Therapeutics emerges from stealth with data published in Science demonstrating the first potential drug intervention for Epstein-Barr Virus (EBV) driven disease 4BIO Capital incubated company [...]
Oxurion Announces Results on the Annual Shareholders’ Meeting of 16 May 2024
23/05/2024
Oxurion Announces Results on the Annual Shareholders’ Meeting of 16 May 2024 Leuven, BELGIUM – 23 May, 2024 – 07.00 PM CET – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, [...]
Extendicare Announces Voting Results for its 2024 Annual Meeting of Shareholders
23/05/2024
MARKHAM, Ontario, May 23, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today announced the results of matters voted on at its annual meeting of shareholders held on May 23, 2024 [...]
Community and union leaders announce legal action, demand Ford declare a moratorium to save the Durham hospital
23/05/2024
TORONTO, May 23, 2024 (GLOBE NEWSWIRE) -- The Durham hospital, located in Grey County, dates back t o 1910 . Its community supported its survival through two World Wars, the Great Depression, amalgamation, and many [...]
Sequana Medical announces results of Annual and Extraordinary General Meetings of Shareholders
23/05/2024
PRESS RELEASE REGULATED INFORMATION 23 May 2024, 06:00 pm CEST Ghent, Belgium – 23 May 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " Sequana Medical "), a pioneer in the treatment of fluid [...]
TruBridge Receives HFMA Peer Review Designation
23/05/2024
CHICAGO, May 23, 2024 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) recently reviewed TruBridge Medical Coding Services, using the Peer Review process. After undergoing rigorous review, [...]
Kno2 and Docusign Revolutionize Provider-to-Provider Signature Workflows in Healthcare
23/05/2024
BOISE, Idaho, May 23, 2024 (GLOBE NEWSWIRE) -- Kno2®, the leader in interoperable healthcare communication is excited to announce the transformation of provider-to-provider signature workflows in the healthcare industry [...]
New York Blood Center Enterprises Celebrates the Expansion of Cell & Gene Therapy GMP Manufacturing Capabilities at the Grand Opening of Louisville, Kentucky Site
23/05/2024
NEW YORK and LOUISVILLE, Ky., May 23, 2024 (GLOBE NEWSWIRE) -- Comprehensive Cell Solutions (CCS), a business unit of New York Blood Center Enterprises (NYBCe), announced today the grand opening of its GMP facility, [...]
Syneos Health Leaders Recognized as PM360 ELITE 100 Award Recipients
23/05/2024
Honored for Notable Biopharmaceutical Industry Impact MORRISVILLE, N.C., May 23, 2024 (GLOBE NEWSWIRE) -- Syneos Health ® , a leading fully integrated biopharmaceutical solutions organization, today announced PM360 has [...]
Syntekabio to Showcase Advanced AI Drug Discovery Technologies at BIO International Convention 2024
23/05/2024
Explore Syntekabio's Cutting-Edge Solutions at Booth 5435 NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- Syntekabio (226330.KQ), a global artificial intelligence (AI) drug discovery pioneer, today announced its [...]

Pages